Lantern Pharma, Inc. (LTRN)
2.335
+0.12
(+5.18%)
USD |
NASDAQ |
Apr 14, 16:00
2.39
+0.06
(+2.36%)
After-Hours: 19:51
Lantern Pharma Cash from Investing (TTM) : 11.06M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Vertex Pharmaceuticals, Inc. | -945.40M |
| BioVie, Inc. | 0.00 |
| Acurx Pharmaceuticals, Inc. | 0.00 |
| ACADIA Pharmaceuticals, Inc. | -302.56M |
| Alnylam Pharmaceuticals, Inc. | 436.33M |